Pancreatic Cancer Research

ResearcherUniversidad de GranadaActive in the last 2 years

Raúl Ortíz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8409-5235; OpenAlex author ID A5059210596. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers

Papers 9

  1. Nanoparticles Bounded to Interfering RNAs as a Therapy for Pancreatic Cancer: A Systematic Review. Co-author DOI 10.1002/wnan.2013↗
  2. Fungi-Derived Bioactive Compounds as Potential Therapeutic Agents for Pancreatic Cancer: A Systematic Review. Co-author DOI 10.3390/microorganisms12081527↗
  3. Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer. Last author DOI 10.2147/ijn.s415631↗
  4. PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine. Last author DOI 10.1016/j.biopha.2022.113669↗
  5. Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress. Co-author DOI 10.3390/cancers13092058↗
  6. The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study. Last author DOI 10.3390/cancers13133169↗
  7. Proteomic biomarkers in body fluids associated with pancreatic cancer. Co-author DOI 10.18632/oncotarget.24654↗
  8. Current Status of Immunotherapy Treatments for Pancreatic Cancer. Co-author DOI 10.1097/mcg.0000000000000623↗
  9. Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. Co-author DOI 10.1007/s10620-014-3291-3↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Consolación Melguizo · 9 shared papers, 2014–2024 · strength 1.37
  2. Jose Carlos Prados · 9 shared papers, 2014–2024 · strength 1.37
  3. Francisco Quiñonero · 6 shared papers, 2021–2024 · strength 1.18
  4. Cristina Jiménez‐Luna · 5 shared papers, 2014–2023 · strength 0.53
  5. Gloria Perazzoli · 3 shared papers, 2021–2023 · strength 0.48
  6. Patricia Lara · 1 shared paper, 2024 · strength 0.28
  7. Carolina Torres · 3 shared papers, 2014–2018 · strength 0.19
  8. Octavio Caba · 3 shared papers, 2014–2018 · strength 0.19
  9. Kevin Doello · 1 shared paper, 2021 · strength 0.14
  10. Joaquina Martínez-Galán · 1 shared paper, 2018 · strength 0.09
  11. Antonia Aránega · 1 shared paper, 2014 · strength 0.04
  12. Sonia Perales · 1 shared paper, 2014 · strength 0.04
  13. Ana Linares · 1 shared paper, 2014 · strength 0.04
  14. Antonio Irigoyen · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.